LGALS3 and neoplasm: These 2 mechanisms interfere with the tumor-specific immune response, as evidenced by previous studies.[42–44] Regarding the mechanism, an in vitro experiment revealed that Gal-3 has the ability to induce TCR glycosylation and cause irreversible changes to the T-cell genome.